Hester Biosciences (NSE:HESTERBIO, BOM:524669) posted a jump in its consolidated attributable net profit to 164.4 million Indian rupees in the fiscal first quarter ended June 30 against 63.4 million rupees a year ago.
Earnings per share were up at 20.33 rupees compared with 8.80 rupees a year earlier, according to a Friday filing to the stock exchanges.
Revenue from operations in fiscal Q1 also climbed to 841.1 million rupees from 822.7 million rupees a year ago.
Shares of the company were up 12% in after-market hours.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.